Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease
Top Cited Papers
Open Access
- 26 June 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 53 (12), 2196-2203
- https://doi.org/10.1093/rheumatology/keu258
Abstract
Objective. PM and DM are often complicated by interstitial lung disease (ILD). In this study we aimed to evaluate various serum cytokines in patients with PM/DM with ILD so as to clarify the differences in pathophysiology between anti-melanoma differentiation-associated gene 5 antibody-associated ILD (anti-MDA5-ILD) and anti-aminoacyl tRNA synthetase antibody-associated ILD (anti-ARS-ILD). Methods. We evaluated the serum cytokine profiles of 38 patients with PM/DM and compared the cytokine profiles of the non-ILD and ILD subsets as well as the anti-MDA5-ILD and anti-ARS-ILD subsets. Results. The myositis intention-to-treat activity index score, which indicates whole disease activity, significantly correlated with serum IL-6, IL-8, TNF-α and IP-10. These cytokine levels were significantly higher in the ILD subset than the non-ILD subset and were lower in the ILD subset following treatment. By multivariate analysis, TNF-α was the most significant cytokine [P = 0.0006, odds ratio (OR) 1.4, CI 1.1, 2.2] associated with PM/DM with ILD. IL-8 levels were significantly higher in anti-MDA5-ILD than in anti-ARS-ILD, although IL-6, TNF-α and IP-10 levels were high in both subsets. IL-8 was the most significant cytokine (P = 0.0006, OR 1.5, CI 1.1, 3.0) associated with anti-MDA5-ILD by multivariate analysis. Moreover, the ratio of IL-4 to IFN-γ was lower in anti-MDA5-ILD than in anti-ARS-ILD. Conclusion. IL-6, IL-8, TNF-α and IP-10 are associated with global disease activity in PM/DM. These cytokine levels were high, especially in the ILD subset. Serum IL-8 levels and the balance between IL-4 and IFN-γ may contribute to the differences in pathophysiology between anti-ARS-ILD and anti-MDA5-ILD.Keywords
This publication has 29 references indexed in Scilit:
- Idiopathic Inflammatory Myopathies: Current Trends in Pathogenesis, Clinical Features, and Up-to-Date Treatment RecommendationsMayo Clinic Proceedings, 2013
- New approaches to the assessment and treatment of the idiopathic inflammatory myopathiesAnnals Of The Rheumatic Diseases, 2012
- Morbidity and Mortality in Adult Polymyositis and DermatomyositisCurrent Rheumatology Reports, 2012
- Interstitial Lung Disease in Myositis: Clinical Subsets, Biomarkers, and TreatmentCurrent Rheumatology Reports, 2012
- Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfallsCurrent Opinion in Rheumatology, 2010
- The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibodyRheumatology, 2009
- Role of cytokines and chemokines in idiopathic inflammatory myopathiesCurrent Opinion in Rheumatology, 2009
- RNA helicase encoded by melanoma differentiation–associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung diseaseArthritis & Rheumatism, 2009
- Characterization and peripheral blood biomarker assessment of anti–Jo‐1 antibody–positive interstitial lung diseaseArthritis & Rheumatism, 2009
- DermatomyositisThe Lancet, 2000